首页> 外文期刊>Chemistry Select >Design and Synthesis of 2-Amino-thiophene-proline-conjugates and Their Anti-tubercular Activity against Mycobacterium Tuberculosis H37Ra
【24h】

Design and Synthesis of 2-Amino-thiophene-proline-conjugates and Their Anti-tubercular Activity against Mycobacterium Tuberculosis H37Ra

机译:2-氨基 - 噻吩 - 缀合物的设计和合成及其针对结核分枝杆菌H37RA的抗结核活性

获取原文
获取原文并翻译 | 示例
           

摘要

The emergence of extensively drug resistant tuberculosis(XDRTB)and multi-drug resistant tuberculosis(MDR-TB)has necessitated the development of new drugs with short chemotherapy treatment regime and cost effectiveness.To overcome these challenges,we are reporting the synthesis of a series of 2-amino-thiophene-proline-conjugates which show potent invitro and ex-vivo anti-tubercular(anti-TB)activity against mycobacterium tuberculosis(mtb)H37Ra.The synthesis of these 2-amino-thiophene-proline-conjugates was carried out via solution phase peptide coupling reactions using methyl-2-aminothiophene-3-carboxylate 8 as an intermediate obtained by modified gewald reaction.Intermediate 8 was coupled with different amino acids to obtain dipeptides 3,4,5,6a and 7.Priliminary anti-TB assay data encoureaged us to synthesize modified proline derivatives 6b-6k via formation of a benzoxazinone intermediate 16.Most of these conjugates are active against mtb H37Ra in both active(A)and dormant(D)strains.They are also active against drug resistant mtb H37Ra strains.A trifluoroethyl ester analog,6i was the most potent among the series [MIC 1 μg/mL] along with 6f and 6g [MIC 2–6 μg/mL].Cytotoxicity studies suggested that,these compounds are less cytotoxic to human cell lines HeLa,MCF-7,HUVEC and hence possess high selectivity index(SI).Docking studies revealed that the binding mode of most active compounds 6i,6g and 6f is in accordance with their bioactivity studies having docking score ?? 8.969,?? 8.446 and ?? 7.865,respectively.Moreover,in silico ADME properties suggest that all the compounds possess drug like properties.
机译:广泛的耐药性结核病(XDRTB)和多药耐药性结核病(MDR-TB)的出现已经需要以短暂的化学疗法治疗方案和成本效益来开发新药。要克服这些挑战,我们正在报告一系列系列的综合2-氨基 - 噻吩 - 丙二相结合物,这些偶联物显示出对结核分枝杆菌(MTB)H37RA的有效的抗菌和前抗链球菌(抗TB)活性。通过甲基-2-氨基噻吩-3-羧酸盐8作为通过改良的gewald反应获得的中间体,通过溶液相肽偶联反应出现。间介质8与不同的氨基酸偶联以获得二肽3,4,5,6A和7. 7.特定抗抗抗菌-TB测定数据鼓励我们通过形成苯唑嗪中间体16.在活性(A)和休眠(D)菌株中,这些结合物中的大多数均具有对MTB H37RA的活性。 y也对抗药性MTB H37RA菌株具有活跃性。A三氟乙酯类似物,6i,6i是[MIC1μg/ml]中最有效的,以及6F和6G [MIC2-6μg/ml] .Cytototoxicity研究表明, ,这些化合物对人细胞系HELA,MCF-7,HUVEC及其具有高选择性指数(SI)的细胞毒性较少。造成研究表明,大多数活性化合物6i,6g和6f的结合模式符合其生物活性研究有对接得分? 8.969,?? 8.446和??另外,分别为7.865。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号